138 related articles for article (PubMed ID: 27197290)
1. A Tissue Systems Pathology Assay for High-Risk Barrett's Esophagus.
Critchley-Thorne RJ; Duits LC; Prichard JW; Davison JM; Jobe BA; Campbell BB; Zhang Y; Repa KA; Reese LM; Li J; Diehl DL; Jhala NC; Ginsberg G; DeMarshall M; Foxwell T; Zaidi AH; Lansing Taylor D; Rustgi AK; Bergman JJ; Falk GW
Cancer Epidemiol Biomarkers Prev; 2016 Jun; 25(6):958-68. PubMed ID: 27197290
[TBL] [Abstract][Full Text] [Related]
2. A Tissue Systems Pathology Test Detects Abnormalities Associated with Prevalent High-Grade Dysplasia and Esophageal Cancer in Barrett's Esophagus.
Critchley-Thorne RJ; Davison JM; Prichard JW; Reese LM; Zhang Y; Repa K; Li J; Diehl DL; Jhala NC; Ginsberg GG; DeMarshall M; Foxwell T; Jobe BA; Zaidi AH; Duits LC; Bergman JJ; Rustgi A; Falk GW
Cancer Epidemiol Biomarkers Prev; 2017 Feb; 26(2):240-248. PubMed ID: 27729357
[TBL] [Abstract][Full Text] [Related]
3. A biomarker panel predicts progression of Barrett's esophagus to esophageal adenocarcinoma.
Duits LC; Lao-Sirieix P; Wolf WA; O'Donovan M; Galeano-Dalmau N; Meijer SL; Offerhaus GJA; Redman J; Crawte J; Zeki S; Pouw RE; Chak A; Shaheen NJ; Bergman JJGHM; Fitzgerald RC
Dis Esophagus; 2019 Jan; 32(1):. PubMed ID: 30496496
[TBL] [Abstract][Full Text] [Related]
4. A Tissue Systems Pathology Test Outperforms the Standard-of-Care Variables in Predicting Progression in Patients With Barrett's Esophagus.
Davison JM; Goldblum JR; Duits LC; Khoshiwal AM; Bergman JJ; Falk GW; Diehl DL; Khara HS; Smolko C; Arora M; Siegel JJ; Critchley-Thorne RJ; Thota PN
Clin Transl Gastroenterol; 2023 Nov; 14(11):e00631. PubMed ID: 37622544
[TBL] [Abstract][Full Text] [Related]
5. Significance of Crypt Atypia in Barrett's Esophagus: A Clinical, Molecular, and Outcome Study.
Wang HH; Patil DT; Paulson TG; Grady WM; Odze RD
Clin Gastroenterol Hepatol; 2024 Apr; 22(4):741-748.e2. PubMed ID: 37879518
[TBL] [Abstract][Full Text] [Related]
6. CDX-2 Expression in Esophageal Biopsies Without Goblet Cell Intestinal Metaplasia May Be Predictive of Barrett's Esophagus.
Saller J; Al Diffalha S; Neill K; Bhaskar RA; Oliveri C; Boulware D; Levine H; Kalvaria I; Corbett FS; Khazanchi A; Klapman J; Coppola D
Dig Dis Sci; 2020 Jul; 65(7):1992-1998. PubMed ID: 31691172
[TBL] [Abstract][Full Text] [Related]
7. Detection of dysplasia in Barrett's esophagus with in vivo depth-resolved nuclear morphology measurements.
Terry NG; Zhu Y; Rinehart MT; Brown WJ; Gebhart SC; Bright S; Carretta E; Ziefle CG; Panjehpour M; Galanko J; Madanick RD; Dellon ES; Trembath D; Bennett A; Goldblum JR; Overholt BF; Woosley JT; Shaheen NJ; Wax A
Gastroenterology; 2011 Jan; 140(1):42-50. PubMed ID: 20854820
[TBL] [Abstract][Full Text] [Related]
8. A Randomized Controlled Study on Clinical Adherence to Evidence-Based Guidelines in the Management of Simulated Patients With Barrett's Esophagus and the Clinical Utility of a Tissue Systems Pathology Test: Results From Q-TAB.
Peabody JW; Cruz JDC; Ganesan D; Paculdo D; Critchley-Thorne RJ; Wani S; Shaheen NJ
Clin Transl Gastroenterol; 2024 Jan; 15(1):e00644. PubMed ID: 37767993
[TBL] [Abstract][Full Text] [Related]
9. Prediction of neoplastic progression in Barrett's esophagus using nanoscale nuclear architecture mapping: a pilot study.
Thota PN; Nasibli J; Kumar P; Sanaka MR; Chak A; Zhang X; Liu X; Uttam S; Liu Y
Gastrointest Endosc; 2022 Jun; 95(6):1239-1246. PubMed ID: 35065946
[TBL] [Abstract][Full Text] [Related]
10. Matrix metalloproteinase (MMP)-7 in Barrett's esophagus and esophageal adenocarcinoma: expression, metabolism, and functional significance.
Garalla HM; Lertkowit N; Tiszlavicz L; Reisz Z; Holmberg C; Beynon R; Simpson D; Varga A; Kumar JD; Dodd S; Pritchard DM; Moore AR; Rosztóczy AI; Wittman T; Simpson A; Dockray GJ; Varro A
Physiol Rep; 2018 May; 6(10):e13683. PubMed ID: 29845775
[TBL] [Abstract][Full Text] [Related]
11. The Salivary Microbiome and Predicted Metabolite Production Are Associated with Barrett's Esophagus and High-Grade Dysplasia or Adenocarcinoma.
Solfisburg QS; Baldini F; Baldwin-Hunter B; Austin GI; Lee HH; Park H; Freedberg DE; Lightdale CJ; Korem T; Abrams JA
Cancer Epidemiol Biomarkers Prev; 2024 Mar; 33(3):371-380. PubMed ID: 38117184
[TBL] [Abstract][Full Text] [Related]
12. Development of Electronic Health Record-Based Machine Learning Models to Predict Barrett's Esophagus and Esophageal Adenocarcinoma Risk.
Iyer PG; Sachdeva K; Leggett CL; Codipilly DC; Abbas H; Anderson K; Kisiel JB; Asfahan S; Awasthi S; Anand P; Kumar M P; Singh SP; Shukla S; Bade S; Mahto C; Singh N; Yadav S; Padhye C
Clin Transl Gastroenterol; 2023 Oct; 14(10):e00637. PubMed ID: 37698203
[TBL] [Abstract][Full Text] [Related]
13. Artificial Intelligence-Triaged 3-Dimensional Pathology to Improve Detection of Esophageal Neoplasia While Reducing Pathologist Workloads.
Erion Barner LA; Gao G; Reddi DM; Lan L; Burke W; Mahmood F; Grady WM; Liu JTC
Mod Pathol; 2023 Dec; 36(12):100322. PubMed ID: 37657711
[TBL] [Abstract][Full Text] [Related]
14. Aberrant vimentin methylation is characteristic of upper gastrointestinal pathologies.
Moinova H; Leidner RS; Ravi L; Lutterbaugh J; Barnholtz-Sloan JS; Chen Y; Chak A; Markowitz SD; Willis JE
Cancer Epidemiol Biomarkers Prev; 2012 Apr; 21(4):594-600. PubMed ID: 22315367
[TBL] [Abstract][Full Text] [Related]
15. TSP-9: A Barrett's Esophagus Biomarker Better Than Pathologists?
Rubenstein JH; Stachler MD
Gastroenterology; 2023 Nov; 165(5):1106-1107. PubMed ID: 37659675
[No Abstract] [Full Text] [Related]
16. Using Natural Language Processing to Automatically Identify Dysplasia in Pathology Reports for Patients With Barrett's Esophagus.
Nguyen Wenker T; Natarajan Y; Caskey K; Novoa F; Mansour N; Pham HA; Hou JK; El-Serag HB; Thrift AP
Clin Gastroenterol Hepatol; 2023 May; 21(5):1198-1204. PubMed ID: 36115659
[TBL] [Abstract][Full Text] [Related]
17. Multicenter, Prospective Trial of Nonendoscopic Biomarker-Driven Detection of Barrett's Esophagus and Esophageal Adenocarcinoma.
Moinova HR; Verma S; Dumot J; Faulx A; Iyer PG; Canto MI; Wang JS; Shaheen NJ; Thota PN; Aklog L; Willis JE; Markowitz SD; Chak A
Am J Gastroenterol; 2024 May; ():. PubMed ID: 38686933
[TBL] [Abstract][Full Text] [Related]
18. Algorithm Training and Testing for a Nonendoscopic Barrett's Esophagus Detection Test in Prospective Multicenter Cohorts.
Iyer PG; Slettedahl SW; Mahoney DW; Giakoumopoulos M; Olson MC; Krockenberger M; Taylor WR; Foote P; Berger C; Leggett C; Wu TT; Antpack E; Falk GW; Ginsberg GG; Abrams JA; Lightdale CJ; Ramirez F; Kahn A; Wolfsen H; Konda V; Trindade AJ; Kisiel JB
Clin Gastroenterol Hepatol; 2024 Mar; ():. PubMed ID: 38513982
[TBL] [Abstract][Full Text] [Related]
19. Development and validation of a risk prediction model to diagnose Barrett's oesophagus (MARK-BE): a case-control machine learning approach.
Rosenfeld A; Graham DG; Jevons S; Ariza J; Hagan D; Wilson A; Lovat SJ; ; Sami SS; Ahmad OF; Novelli M; Rodriguez Justo M; Winstanley A; Heifetz EM; Ben-Zecharia M; Noiman U; Fitzgerald RC; Sasieni P; Lovat LB
Lancet Digit Health; 2020 Jan; 2(1):E37-E48. PubMed ID: 32133440
[TBL] [Abstract][Full Text] [Related]
20. Quantitative serum glycomics of esophageal adenocarcinoma and other esophageal disease onsets.
Mechref Y; Hussein A; Bekesova S; Pungpapong V; Zhang M; Dobrolecki LE; Hickey RJ; Hammoud ZT; Novotny MV
J Proteome Res; 2009 Jun; 8(6):2656-66. PubMed ID: 19441788
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
